Where will AGN go in 2000. They have one year left before BOL makes its run. Can AGN compete with Alcon and then be able to withstand the "new" BOL. AGN has to grow and with Alcon having a nice pipeline of products for year 2000, where is the growth going to come from. Is AGN a RX or a Biotech for the decade of 2000.
My sense is not many people care to comment about this sleepy-assed company any more!
Could it be Pyott has done the easy stuff (downsizing, resizing, layoffs, canning people, et. al.) and now faces an uphill-slope in trying to compete in the TOTAL stock market with true growth companies? When the "wire" carries a story about co-selling/marketing with Dura I have some room for suspicion about the lack of substantive news. Afterall, co-selling is neither new nor inventive. Seems they had something similar with Fisons years ago..........
Look for Allergan to team up with another pharmaceutical company to promote their new allergy drop launching this spring. The co-marketing aggreement will allow Allergan to promote to Primary CAre and Allergists. This will play a key role in the success of the drug. As you know Alcon controls the allergy market with close to a 70% market share with Patanol.
Do not know who the partner will be....but there will be one!
makes some sense...old rumor(at least year old) had agn merger w those guys....how about agn 4th q performance...outstanding....now to deal w the lenscare piece.....glad i got back in but wish i had the brains to buy it when it was 40-42...look for 60 in the next couple months(if we dont get a comprehensive market correction).